CD8A and neoplasm: These results indicated that T7-OCT4 vaccine can induced OCT4-specific immune responses, and the anti-tumor effect of T7-OCT4 are possibly centered on the activation of CD8 CTL that recognize specific OCT4 tumor antigen.